At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 80 enrolled
Drug / intervention
combination NRT +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
NRT Sampling and Selection to Increase Medication Adherence
In Brief
A Phase 4 clinical trial evaluating Counseling and combination NRT for Smoking Cessation. Completed, enrolled 80 participants across 1 site.
Detailed Summary
To determine the preliminary impact on Nicotine Replacement Therapy (NRT)adherence and examine the underlying mechanisms of action associated with adherence.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSmoking Cessation
CountriesUnited States
CollaboratorsNational Institute on Drug Abuse (NIDA)
Timeline
Phase 4CompletedFinished
201820192020202120222023202420252026
First PostedSep 2017
Enrollment StartMay 2018
Primary CompletionMay 2020
Study CompletionOct 2020
TodayJul 2026
First PostedSep 8, 2017
Enrollment StartMay 3, 2018
Primary CompletionMay 31, 2020
Study CompletionOct 31, 2020
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 8.8 years ago
Interventions
Counselingbehavioral
Both groups receive smoking cessation counseling although one is focused on medication adherence and addressing barriers to adherence while the other is focused on standard behavioral strategies to quit smoking
combination NRTdrug
Both groups will receive combination NRT to help with smoking cessation